Danaher Looks Like It Could Stall or Turn Lower

Prices appear to be losing upward momentum and overbought when using the stochastic indicator, so caution is in order.
Stocks quotes in this article: DHR

During Jim Cramer's "Mad Money" program on Wednesday night, a caller asked about Danaher Corp. (DHR) .

"This one just continues to rally, and it's not done. Stay long,"  said Cramer.

Let's check out the charts of this science and technology conglomerate and see if there are any targets or appropriate risk points. 

In this daily bar chart of DHR, below, we can see that prices broke out on the upside from a five-month sideways consolidation pattern.

Prices tested the rising 200-day moving average line in early November and gapped above the rising 50-day moving average line in the middle of November. Prices have since continued higher, but the pace of the rise has slowed from late November to January and this can be seen from the lower highs on the 12-day price momentum study. The On-Balance-Volume (OBV) line had a huge move higher in December and trading volume surged for a time, but has since returned to "normal" levels. Prices are in an uptrend, but I would be cautious.  

 
In this weekly bar chart of DHR, below, we can see that prices made a long consolidation pattern around $100 in 2018, before the stock launched a strong advance in 2019. Trading volume and the OBV line only surged in December and the slow stochastic indicator tells us that prices are "overbought." DHR could continue to rise from here, but the indicators suggest a degree of caution.  
 
 
In this daily Point and Figure chart of DHR, below, we can see a potential upside price target around $190. Point and Figure charts focus only on price changes and ignore volume and time.  
 
 
Bottom line strategy: With prices losing upward momentum and overbought when using the stochastic indicator, I would take a cautious stance on DHR. Longs could be held with an appropriate sell stop, but I would not get aggressive at this juncture.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Life Sciences | Conglomerates | Industrials | Market Recon

More from Investing

Bearish Bets: 2 Healthcare Stocks You Should Consider Shorting This Week

Bob Lang

These names are displaying both technical and quantitative deterioration.

Pandemic Should Help This Cereal Maker Remain a Serial Dividend Payer

Chris Versace

Food company General Mills is benefiting as more consumers work from home and dine out less.

Where's the Stock Market Headed Into Year-End? A Technical Look and Strategy

Bruce Kamich

In late August/early September the major indices were making medium-term tops.

The Art of Navigating a Correction

James "Rev Shark" DePorre

Sizable, sudden losses will occur when the market turns. Find ways to use that to your advantage.

Stimulus and Cold Weather Could Light Fresh Fires Under Consumer Tech Spending

Eric Jhonsa

Depending on how a couple of factors play out, growth rates in areas such as gaming and e-commerce could accelerate further.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight